C. Freter

发表

Breast Cancer and Lipid Metabolism

Chunfa Huang, Yun-tao Li, Yifan Tu, 2018 .

Plasma microRNAs as novel biomarkers for early detection of lung cancer.

Yong Wang, Li-Qun Gu, Yong Wang, 2011, International journal of clinical and experimental pathology.

Cholesterol Lowering in Cancer Prevention and Therapy

Chunfa Huang, C. Freter, 2016 .

Phosphoinositide metabolism in human prostate cancer cells in vitro

E. Gelmann, G. Wilding, C. Freter, 1990, The Prostate.

Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines.

S. Khera, C. Freter, A. Wolfson, 1996, Leukemia & lymphoma.

Dexamethasone and suramin inhibit cell proliferation and interleukin-6-mediated immunoglobulin secretion in human lymphoid and multiple myeloma cell lines.

S. Khera, C. Freter, A. Wolfson, 1995, Leukemia & lymphoma.

Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk.

J. Lionberger, C. Freter, M. Schoen, 2018, Leukemia research.

Oolong Tea Extract Induces DNA Damage and Cleavage and Inhibits Breast Cancer Cell Growth and Tumorigenesis

Chunfa Huang, Yifan Tu, C. Freter, 2018, AntiCancer Research.

Thromboprophylaxis and Incidence of Venous Thromboembolism in Patients With Hemophilia A or B Who Underwent High-Risk Orthopedic Surgeries

S. Raza, C. Freter, S. Akbar, 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Alterations in phosphoinositide metabolism associated with 17 beta-estradiol and growth factor treatment of MCF-7 breast cancer cells.

E. Gelmann, M. Lippman, A. Cheville, 1988, Molecular endocrinology.

Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review.

M. Bristow, C. Freter, M. Billingham, 1986, The American journal of medicine.

Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications.

A. Fojo, R. Clarke, M. Lippman, 1993, Cancer research.

Intravascular large cell lymphoma coexisting within hemangiomas of the skin.

M. Rubin, J. Cossman, N. Azumi, 1997, The American journal of surgical pathology.

Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.

R. Nordan, G. Strassmann, C. Freter, 1993, The Journal of clinical investigation.

Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.

Chunfa Huang, Yifan Tu, C. Freter, 2019, Blood advances.

Anti-IgM-mediated growth inhibition of a human B lymphoma cell line is independent of phosphatidylinositol turnover and protein kinase C activation and involves tyrosine phosphorylation.

D. Longo, C. Moratz, M. Beckwith, 1991, Journal of immunology.

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.

R. Mercier, B. Mitchell, K. Rai, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cervical neuroendocrine tumor in a young female with Lynch Syndrome.

L. Layfield, J. Sowers, C. Freter, 2014, Neuro endocrinology letters.

Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.

Edward J. Lee, C. Bloomfield, G. Petroni, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia.

B. Arun, N. Azumi, C. Freter, 1998, Leukemia & lymphoma.

Gaussian decomposition of high-resolution melt curve derivatives for measuring genome-editing efficiency

C. Freter, N. Srinivasakumar, M. Zaboikin, 2017, bioRxiv.

Acquired immunodeficiency syndrome-associated lymphomas.

C. Freter, 1990, Journal of the National Cancer Institute. Monographs.

Insight into Sweet's syndrome and associated-malignancy: a review of the current literature.

S. Raza, J. Shortridge, C. Freter, 2013, International journal of oncology.

Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab.

C. Freter, R. Bobba, C. Kardinal, 2012, The American journal of the medical sciences.

Signaling regulation and role of filamin A cleavage in Ca2+-stimulated migration of androgen receptor-deficient prostate cancer cells

Chunfa Huang, C. Freter, R. Tyler Miller, 2016, Oncotarget.

Gaussian decomposition of high-resolution melt curve derivatives for measuring 1 genome-editing efficiency 2 3 4

C. Freter, N. Srinivasakumar, M. Zaboikin, 2017 .

Postoperative bleeding in an elderly patient from acquired factor V inhibitor: rapid response to immunosuppressive therapy.

C. Freter, R. Bobba, P. Garg, 2011, The American journal of the medical sciences.

Hodgkin's disease treated with neck radiation is associated with increased antibody-dependent cellular cytotoxicity against human extraocular muscle cells.

M. Ringel, R. Howard, K. Burman, 1997, Thyroid : official journal of the American Thyroid Association.

Who Underwent High-Risk Orthopedic Surgeries Thromboprophylaxis and Incidence of Venous Thromboembolism in Patients With Hemophilia A or B

S. Raza, C. Freter, S. Akbar, 2014 .

Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia

Chunfa Huang, Yifan Tu, C. Freter, 2018, Oncotarget.

Lipid Metabolism, Apoptosis and Cancer Therapy

Chunfa Huang, C. Freter, 2015, International journal of molecular sciences.

Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia.

J. Lionberger, C. Freter, M. Schoen, 2017, Anticancer research.

Non-Homologous End Joining and Homology Directed DNA Repair Frequency of Double-Stranded Breaks Introduced by Genome Editing Reagents

C. Freter, N. Srinivasakumar, M. Zaboikin, 2017, PloS one.

Translocation t(11;22) in esthesioneuroblastoma.

A. Gazdar, J. Whang‐Peng, T. Knutsen, 1987, Cancer genetics and cytogenetics.

Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.

S. Bates, D. Salomon, N. Davidson, 1988, Molecular endocrinology.

Molecular detection of bone marrow involvement in intravascular lymphomatosis.

Joseph A. DiGiuseppe, J. Cossman, C. Freter, 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression

R. Clarke, F. Leonessa, T. Skaar, 2004, Breast Cancer Research and Treatment.

Lung cancer screening: from imaging to biomarker

K. Shen, G. Kloecker, C. Freter, 2013, Biomarker Research.

Lung cancer screening: from imaging to biomarker

K. Shen, G. Kloecker, C. Freter, 2013, Biomarker Research.

Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic leukemia cells

Chunfa Huang, C. Freter, Indira Benakanakere, 2014, Experimental Hematology & Oncology.

mTOR Signaling in Renal Disease and Therapy

Chunfa Huang, C. Freter, 2015 .

A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma

D. Schenkein, R. Gingrich, P. Stiff, 2000, Bone Marrow Transplantation.